8.16 USD
↗ 0.20 (2.45%)LIVE (AS OF 03:09 PM EDT)
Immunic, Inc. Common Stock
IMUXNASDAQ • USD
Market: OPEN
IMUX is currently priced at $8.16. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, IMUX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$8.00
High?$8.16
Low?$7.70
Prev. Close?$7.96
Volume?218.3K
Avg. Volume?380.6K
VWAP?$7.94
Rel. Volume?0.57x
Bid / Ask
Bid?$8.05 × 100
Ask?$9.30 × 100
Spread?$1.25
Midpoint?$8.68
Valuation & Ratios
Market Cap?108.6M
Shares Out?13.6M
Float?120.7M
Float %?88.6%
P/E Ratio?N/A
P/B Ratio?0.85
EPS?-$8.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Address
1200 AVENUE OF THE AMERICAS
NEW YORK, X1 10036
Phone: (332) 255-9818
NEW YORK, X1 10036
Phone: (332) 255-9818
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.37Distress
Confidence?48%Low
Short InterestHigh
Short % of Float?1.49%Low
Short Interest?1.8M
Days to Cover?5.0
Free Float120.7M
Avg Daily Volume356.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.05Strong
Quick Ratio?5.05Strong
Cash Ratio?4.96Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.85CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-87.5%WEAK▾
S&P3
ROA?-70.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-88049000
Enterprise Value?$-46488043
Fundamentals ratios updated end of day